GlassScriptPhysician profile
Linda E Stanley
NPI 1376761262
$1,750.29
in general payments reported to CMS, 2019-2025
8 companies · $650 in 2025
The $650 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $84.08 · 2021: $15.51 · 2022: $238 · 2023: $114 · 2024: $125 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $650 · Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $650.00 |
| Food and Beverage | $239.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $650.00 | 2025 | Avitene Ultrafoam |
| Abbott Laboratories | $410.60 | 2019-2022 | |
| Depuy Synthes Sales INC. | $176.18 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $140.74 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $124.99 | 2024 | Caplyta |
| Novo Nordisk INC | $117.78 | 2022 | |
| Intra-Sana Laboratories | $114.49 | 2023 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Abbvie INC. | $15.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.